ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
1,787
Screening encounters
1,912
Diagnostic referrals
354
Outstanding pathways
151

Screening pathway

  1. Screening1,912Encounters
  2. Positive finding637Documented findings
  3. Referral354Diagnostic referrals
  4. Follow-up394Diagnostic visits
  5. Outcome203Resolved pathways

Stage totals use different units. Pending pathways: 151. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0803 · EXP-0803Synthetic · Site D

Full participant history through 2025-11-17, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Triage · VIA · VIA negative
  4. · Surveillance plan · HPV DNA · HPV positive with negative triage · Scheduled for 2027-11-06

Referral-time risk

No matching referral was available at this observation date.

Screened participants

1787 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0962 · Expanded synthetic participant 0962Site D — Community Engagement Programme
EXP-0968 · Expanded synthetic participant 0968Site E — Resource-Constrained Navigation Programme
EXP-0972 · Expanded synthetic participant 0972Site C — Rural Outreach Programme
EXP-0973 · Expanded synthetic participant 0973Site E — Resource-Constrained Navigation Programme
EXP-0975 · Expanded synthetic participant 0975Site A — Urban Referral Hub
EXP-0976 · Expanded synthetic participant 0976Site D — Community Engagement Programme
EXP-0978 · Expanded synthetic participant 0978Site C — Rural Outreach Programme
EXP-0979 · Expanded synthetic participant 0979Site E — Resource-Constrained Navigation Programme
EXP-0983 · Expanded synthetic participant 0983Site B — Peri-Urban Access Programme
EXP-0988 · Expanded synthetic participant 0988Site D — Community Engagement Programme
EXP-0989 · Expanded synthetic participant 0989Site D — Community Engagement Programme
EXP-0992 · Expanded synthetic participant 0992Site B — Peri-Urban Access Programme
EXP-0994 · Expanded synthetic participant 0994Site C — Rural Outreach Programme
EXP-0996 · Expanded synthetic participant 0996Site D — Community Engagement Programme
EXP-0997 · Expanded synthetic participant 0997Site D — Community Engagement Programme
EXP-0998 · Expanded synthetic participant 0998Site C — Rural Outreach Programme
EXP-0999 · Expanded synthetic participant 0999Site E — Resource-Constrained Navigation Programme
EXP-1002 · Expanded synthetic participant 1002Site A — Urban Referral Hub
EXP-1003 · Expanded synthetic participant 1003Site C — Rural Outreach Programme
EXP-1005 · Expanded synthetic participant 1005Site D — Community Engagement Programme
EXP-1010 · Expanded synthetic participant 1010Site A — Urban Referral Hub
EXP-1012 · Expanded synthetic participant 1012Site D — Community Engagement Programme
EXP-1016 · Expanded synthetic participant 1016Site B — Peri-Urban Access Programme
EXP-1017 · Expanded synthetic participant 1017Site D — Community Engagement Programme
EXP-1021 · Expanded synthetic participant 1021Site A — Urban Referral Hub

Programme insights

Encounters by modality

VIA
816
HPV DNA
823
Cytology
273

Navigation activity

Barrier documented
292
Contact attempt
519
Navigation intervention
123
Diagnostic booking
433
Diagnostic visit
394

Documented barriers

Contact difficulty
89
Transport difficulty
100
Appointment coordination
103

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.